Indication
Enthesitis Related Arthritis
2 clinical trials
3 products
Product
IxekizumabClinical trial
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-02-19
Product
AdalimumabClinical trial
An Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Efficacy, Safety and Tolerability up to 4 Years in Patients With Juvenile Idiopathic Arthritis Subtypes of Juvenile Psoriatic Arthritis and Enthesitis Related ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-10-03
Product
AIN457